Ms Kathi Apostolidis, Vice President of the European Cancer Patient Coalition, has joined the Steering Group of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance as an observer of the European Medicines Agency Patients & Consumer Working Party, of which she is a member.

The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance is network coordinated by the European Medicines Agency (EMA). The members of this network are public institutions and contract and research organisations involved in research in pharmacoepidemiology and pharmacovigilance. Research interests are not restricted to the safety of medicines but may include the benefits and risks of medicines, disease epidemiology and drug utilisation.

The Steering Group defines and safeguards the objectives and principles of European Network of Centres for Pharmacoepidemiology and Pharmacovigilance and decides on operational tasks of the network. The Steering Group is the highest authority of European Network of Centres for Pharmacoepidemiology and Pharmacovigilance and thus is its final decision making body. It acts as adjudicator in case of discrepancies or complaints in the context of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance network.


Composition of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance Steering Group 2017-2019:
  

  

No.

Representing

Name

Affiliation

1

ENCePP

Vera Ehrenstein

Department of Clinical Epidemiology, Aarhus University, Denmark

2

ENCePP

Rosa Gini

Agenzia regionale di sanità della Toscana, Florence, Italy

3

ENCePP

Teresa Herdeiro

iBiMED, University of Aveiro, Portugal

4

ENCePP

Olaf Klungel

Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Netherlands

5

ENCePP

Tom MacDonald

Medicines Monitoring Unit (MEMO) and Hypertension Research Centre (HRC), University of Dundee, UK

6

ENCePP

Gianluca Trifirò

University of Messina, Italy

7

EMA

Xavier Kurz (Chair)

European Medicines Agency

8

EMA

Corinne de Vries

European Medicines Agency

9

EMA

Hans-Georg Eichler

European Medicines Agency

10

HMA

Janne Lehmann Knudsen

Lægemiddelstyrelsen - Danish Medicines Agency, Denmark

11

CHMP

Johann Lodewijk Hillege

College ter Beoordeling van Geneesmiddelen, Netherlands

12

COMP

Dinah Duarte

INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, Portugal

13

PRAC

tbc

 

14

PCWP

Kathi Apostolidis

ECPC - European Cancer Patient Coalition

15

ISPE

Yola Moride

Faculty of Pharmacy, Université de Montréal, Canada

16

ISoP

Herve Le Louet

Centre de Pharmacovigilance & Information sur le médicament, Hôpital Henri Mondor, Paris, France

Observer

EFPIA

Patrice Verpillat

Merck Group, Germany

Principal Scientific

Advisor

EMA

Giampiero Mazzaglia

European Medicines Agency

Statistical

Advisor

EMA

Jim Slattery

European Medicines Agency

 
Find out more about Steering Group of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.